Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Longmen Capital is a China-based private equity and venture capital investment firm focused primarily on pharmaceutical, biotech, medical device, diagnostics, and broader healthcare opportunities. The firm operates as a private fund manager rather than a drug developer, so it does not appear to maintain an internal therapeutic pipeline. Public descriptions emphasize early-stage and growth-stage investing in innovative medical and healthcare companies, with a particular interest in translating scientific and technological advances into commercial products. The company is headquartered in Zhuhai with operations in Shenzhen and has invested in dozens of healthcare companies across China. For a biotech analyst, the relevant angle is that Longmen Capital is a specialized healthcare investor and fund manager, not an operating biopharma company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhuhai Longmen Capital Management.